Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytel and Axio have merged to create the largest global biometrics organization focused on delivering advanced analytical solutions for the life sciences industry.
read more
Wednesday, March 10, 2021
Cytel has launched East Bayes®, a web-based extension of the East® platform that enables adoption of computationally intensive Bayesian clinical trial designs.
read more
CYTENA a provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a biologics CDMO that manufactures recombinant proteins.
read more
Wednesday, February 03, 2021
Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
read more
Thursday, February 01, 2024
Cytomos announced the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser.
read more
Friday, February 11, 2022
CytoReason has established itself as a global leader in computational modeling of human diseases. The company's multidisciplinary team of 65 leading biologists, bioinformaticians and data engineers has developed a technology that enables pharma and ...
read more
CytoReason has entered into a collaboration agreement with Pfizer that will leverage CytoReason’s cell-centered models of the immune system.
read more
Wednesday, October 03, 2018
CytoSen Therapeutics and KBI Biopharma announced a strategic partnership to manufacture therapeutic Natural Killer cells using a proprietary and scalable, closed system manufacturing process.
read more
Tuesday, September 15, 2020
CytoSMART Technologies announced the launch of a new automated live-cell imaging system designed for long-term experiments, comparison studies, and large laboratory teams.
read more
Thursday, November 19, 2020
CytoSMART Technologies announced its first fluorescence live-cell imager.
read more
Monday, December 11, 2023
Cytovance Biologics has revealed a strategic alliance with Contract Development and Manufacturing Organization (CDMO) Alcami Corporation, aimed at enhancing its capabilities in large molecule biologic manufacturing and sterile fill-finish services.
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Cytovance® Biologics has announced the appointment of Dr. Jesse McCool to Chief Executive Officer.
read more
Thursday, February 06, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, broke ground on an expansion facility to contain both manufacturing operations and GMP warehousing. The multi-million dollar capital ...
read more
Cytovance® Biologics announced it has received a notification letter and an EIRs from the FDA for its Oklahoma City site, FEI registration numbers: 3006341547.
read more